Biotechnology Stocks
| # | Son 7 Gün | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1722 | BEAM Beam Therapeutics Inc. - Common Stock | 28.77 USD | -3.33% | +7.47% | +13.05% | +71.45% | 2.97 B USD | ||
| 1724 | IRON Disc Medicine, Inc. - Common Stock | 80.34 USD | +0.66% | +2.96% | +7.95% | +33.06% | 3.08 B USD | ||
| 1749 | ZLAB Zai Lab Limited - American Depositary Shares | 25.31 USD | -2.69% | -0.35% | +32.24% | -5.17% | 2.84 B USD | ||
| 1785 | NRIX Nurix Therapeutics, Inc. - Common stock | 26.06 USD | -2.47% | -3.12% | +8.72% | +132.47% | 2.70 B USD | ||
| 1791 | VRDN Viridian Therapeutics, Inc. - Common Stock | 24.16 USD | -0.54% | +6.15% | +23.96% | +7.62% | 2.74 B USD | ||
| 1796 | ATAI AtaiBeckley Inc. - Common Stock | 7.35 USD | -0.41% | +1.52% | +2.51% | +86.08% | 2.73 B USD | ||
| 1839 | PGEN Precigen, Inc. - Common Stock | 7.04 USD | -2.22% | +9.66% | +30.61% | +68.42% | 2.52 B USD | ||
| 1846 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.43 USD | -2.95% | -5.01% | -1.75% | +126.66% | 2.48 B USD | ||
| 1851 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.85 USD | +0.08% | -1.19% | -5.55% | -13.80% | 2.55 B USD | ||
| 1854 | NKTR Nektar Therapeutics - Common Stock | 71.62 USD | -3.24% | +0.14% | +0.87% | -2.25% | 2.45 B USD | ||
| 1876 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.54 USD | -0.10% | -1.55% | -1.04% | +10.93% | 2.44 B USD | ||
| 1878 | OCUL Ocular Therapeutix, Inc. - Common Stock | 10.80 USD | -2.53% | -1.64% | +25.00% | -6.09% | 2.37 B USD | ||
| 1879 | NUVB Nuvation Bio Inc. Class A Common Stock | 6.74 USD | -2.74% | +7.67% | +1.97% | +131.62% | 2.37 B USD | ||
| 1886 | KOD Kodiak Sciences Inc - Common Stock | 37.07 USD | -3.29% | -12.18% | -10.48% | +261.66% | 2.33 B USD | ||
| 1899 | PHVS Pharvaris N.V. - Ordinary Shares | 36.16 USD | -0.30% | +2.73% | +4.66% | +56.88% | 2.36 B USD | ||
| 1903 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.69 USD | +4.37% | +7.64% | -6.26% | +13.28% | 2.43 B USD | ||
| 1913 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.54 USD | -2.82% | -5.52% | +10.94% | +139.68% | 2.23 B USD | ||
| 1921 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.11 USD | -2.11% | -0.83% | -7.75% | -37.80% | 2.22 B USD | ||
| 1936 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 8.46 USD | -2.08% | +49.21% | +24.41% | +245.31% | 2.20 B USD | ||
| 1939 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 38.00 USD | -0.39% | -0.76% | +6.65% | +22.98% | 2.21 B USD |
Haberler Biotechnology Stocks
Deutsche Bank, argenx hissesini değerleme nedeniyle Tut’a düşürdü
Monte Rosa Therapeutics hissesi neden düşüyor?
Biomea Fusion hisseleri diyabet çalışması kayıt tamamlanmasıyla yükseldi
Monte Rosa hisseleri faz 2 prostat kanseri çalışması başlarken düştü
H.C. Wainwright, Biomea Fusion hissesi için hedef fiyatı korudu
Crinetics Pharmaceuticals hissesi 84,8 dolarda zirve yaptı
FDA, Capricor’un deramiocel incelemesini 22 Kasım’a uzattı
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |